Fragmented QRS complex could predict all-cause mortality in patients with connective tissue disease-associated pulmonary arterial hypertension.
Sign Up to like & getrecommendations! Published in 2024 at "Rheumatology"
DOI: 10.1093/rheumatology/keae084
Abstract: OBJECTIVES To investigate the prognostic impact and pathophysiological characteristics of fragmented QRS complex (fQRS) on patients with connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH). METHODS This was a multicentre retrospective study recruiting 141 patients with… read more here.
Keywords: ctd pah; cause mortality; fqrs; change ... See more keywords
A Noninvasive Prognostic Model for Pulmonary Arterial Hypertension Associated With Connective Tissue Diseases Based on Multislice Chest Computed Tomography Parameters.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of thoracic imaging"
DOI: 10.1097/rti.0000000000000855
Abstract: PURPOSE Patients with connective tissue diseases (CTDs) and pulmonary arterial hypertension (PAH) have a poor prognosis, and there is a lack of effective noninvasive prognostic tools. This study aimed to retrospectively analyze clinical data and… read more here.
Keywords: ctd pah; connective tissue; model; noninvasive prognostic ... See more keywords
AB1139 DIAGNOSTICIS AND PROGNOSTICIS SIGNIFICANCE OF CHEST CT EVALUATION OF SMALL PULMONARY VESSELS IN CONNECTIVE TISSUE DISEASES WITH PULMONARY ARTERIAL HYPERTENSION.
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.3063
Abstract: Pulmonary arterial hypertension (PAH) is a fatal complication of connective tissue diseases (CTDs). Chest CT has been increasingly used in the evaluation of patients with suspected PH noninvasively but there is a paucity of studies.Our… read more here.
Keywords: evaluation; pulmonary arterial; hypertension; arterial hypertension ... See more keywords
Clinical use of macitentan in the treatment of connective tissue disease-associated pulmonary arterial hypertension
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Thoracic Disease"
DOI: 10.21037/jtd-24-151
Abstract: Background Connective tissue disease (CTD) is the second most common cause of the pulmonary arterial hypertension (PAH). Currently, clinical data concerning CTD-PAH is scarce. Our study aimed to assess the efficacy and safety of macitentan… read more here.
Keywords: ctd pah; disease; treatment; macitentan ... See more keywords
Molecular Hydrogen Therapy in Sjögren’s Syndrome With Pulmonary Arterial Hypertension and Right-sided Heart Failure: A Case Report of Improved Immune Markers Including Treg, B Cells and Plasma Cell
Sign Up to like & getrecommendations! Published in 2024 at "In Vivo"
DOI: 10.21873/invivo.13797
Abstract: Background/Aim: Connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) is a severe complication characterized by elevated pulmonary artery pressure, which can lead to right heart failure and death, if untreated. Standard treatments often fail to adequately… read more here.
Keywords: ctd pah; therapy; molecular hydrogen; case ... See more keywords
Text Mining-Based Drug Discovery for Connective Tissue Disease–Associated Pulmonary Arterial Hypertension
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.743210
Abstract: Background: The current medical treatments for connective tissue disease–associated pulmonary arterial hypertension (CTD-PAH) do not show favorable efficiency for all patients, and identification of novel drugs is desired. Methods: Text mining was performed to obtain… read more here.
Keywords: text mining; connective tissue; ctd pah; drug ... See more keywords
Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24044178
Abstract: Pulmonary arterial hypertension (PAH) is a life-threatening complication of connective tissue diseases (CTDs) characterised by increased pulmonary arterial pressure and pulmonary vascular resistance. CTD-PAH is the result of a complex interplay among endothelial dysfunction and… read more here.
Keywords: ctd pah; arterial hypertension; serum biomarkers; pulmonary arterial ... See more keywords